A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Status:
RECRUITING

Trial end date:
2027-10-01

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.

PHASE2

Inmagene LLC